GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmena SA (WAR:PHR) » Definitions » PEG Ratio

Pharmena (WAR:PHR) PEG Ratio : N/A (As of Mar. 31, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Pharmena PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Pharmena's PE Ratio without NRI is 0.00. Pharmena's 5-Year EBITDA growth rate is 0.00%. Therefore, Pharmena's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Pharmena's PEG Ratio or its related term are showing as below:



WAR:PHR's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.355
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Pharmena PEG Ratio Historical Data

The historical data trend for Pharmena's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmena PEG Ratio Chart

Pharmena Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pharmena Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pharmena's PEG Ratio

For the Biotechnology subindustry, Pharmena's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmena's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmena's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Pharmena's PEG Ratio falls into.


;
;

Pharmena PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Pharmena's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Pharmena  (WAR:PHR) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Pharmena PEG Ratio Related Terms

Thank you for viewing the detailed overview of Pharmena's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmena Business Description

Traded in Other Exchanges
N/A
Address
Ulica Wolczanska 178, Lodz, POL, 90-530
Pharmena SA produces cosmeceuticals and pharmaceuticals. The company's activity focuses on three areas such as research in the USA and Canada on the application of selected pyridinium salts in medicine in order to develop an anti-atherosclerosis drug on a global scale, Production and sales of innovative patented dermocosmetics and introduction into the market of an innovative dietary supplement for atherosclerosis prophylaxis. Its products include Menavitin, Dermena, Allerco and Thermi.

Pharmena Headlines

From GuruFocus

Phreesia Inc (PHR) Shares Down 3.58% on Oct 23

By GuruFocus News 10-23-2024

Phreesia Inc (PHR) Shares Up 3.38% on Feb 13

By GuruFocus News 02-13-2025

Q3 2025 Phreesia Inc Earnings Call Transcript

By GuruFocus News 12-10-2024

Phreesia Inc (PHR) Trading 4.27% Higher on Nov 19

By GuruFocus News 11-19-2024

Phreesia Inc (PHR) Trading 3.79% Higher on Dec 6

By GuruFocus News 12-06-2024

Phreesia Inc (PHR) Stock Price Up 3.11% on Jan 28

By GuruFocus News 01-28-2025

Phreesia Inc (PHR) Stock Price Up 3.26% on Nov 22

By GuruFocus News 11-22-2024